Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Twan Lammers

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
Pharmacological Research|November 21, 2016
Tumor-targeted nanomedicines for cancer theranosticsAlexandra G Arranja, Vertika Pathak, Twan Lammers, et al.
Cellular Signalling|August 8, 2020
Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cellsSteffen K Meurer, Okan Tezcan, Twan Lammers, et al.
Nature Reviews Bioengineering|October 8, 2024
Nanoparticle Delivery to Tumours: From EPR and ATR Mechanisms to Clinical ImpactAnshuman Dasgupta, Alexandros Marios Sofias, Fabian Kiessling, et al.
Nanoscale|August 15, 2024
Assessing inorganic nanoparticle toxicity through omics approachesYanchen Li, Christopher Vulpe, Twan Lammers, et al.
Radiology|September 24, 2014
Nanoparticles for imaging: top or flop?Fabian Kiessling, Marianne E Mertens, Jan Grimm, et al.
Advanced Drug Delivery Reviews|January 25, 2024
Image-guided drug delivery: Biomedical and imaging advancesAlexandros Marios Sofias, Bing Guo, Jian Xu, et al.
Advanced Drug Delivery Reviews|January 25, 2024
Image-guided drug delivery: Nanoparticle and probe advancesBing Guo, Alexandros Marios Sofias, Twan Lammers, et al.
Advanced Drug Delivery Reviews|August 23, 2022
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPRMohamadreza Amin, Twan Lammers, Timo L M Ten Hagen
Theranostics|July 21, 2020
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacyYang Shi, Roy van der Meel, Xiaoyuan Chen, et al.
Scientific Reports|July 29, 2018
Radiomic analysis of contrast-enhanced ultrasound dataBenjamin Theek, Tatjana Opacic, Zuzanna Magnuska, et al.
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Pharmacological Research|November 21, 2016
Tumor-targeted nanomedicines for cancer theranosticsAlexandra G Arranja, Vertika Pathak, Twan Lammers, et al.
Cellular Signalling|August 8, 2020
Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cellsSteffen K Meurer, Okan Tezcan, Twan Lammers, et al.
Nature Reviews Bioengineering|October 8, 2024
Nanoparticle Delivery to Tumours: From EPR and ATR Mechanisms to Clinical ImpactAnshuman Dasgupta, Alexandros Marios Sofias, Fabian Kiessling, et al.
Nanoscale|August 15, 2024
Assessing inorganic nanoparticle toxicity through omics approachesYanchen Li, Christopher Vulpe, Twan Lammers, et al.
Radiology|September 24, 2014
Nanoparticles for imaging: top or flop?Fabian Kiessling, Marianne E Mertens, Jan Grimm, et al.
Advanced Drug Delivery Reviews|January 25, 2024
Image-guided drug delivery: Biomedical and imaging advancesAlexandros Marios Sofias, Bing Guo, Jian Xu, et al.
Advanced Drug Delivery Reviews|January 25, 2024
Image-guided drug delivery: Nanoparticle and probe advancesBing Guo, Alexandros Marios Sofias, Twan Lammers, et al.
Advanced Drug Delivery Reviews|August 23, 2022
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPRMohamadreza Amin, Twan Lammers, Timo L M Ten Hagen
Theranostics|July 21, 2020
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacyYang Shi, Roy van der Meel, Xiaoyuan Chen, et al.
Scientific Reports|July 29, 2018
Radiomic analysis of contrast-enhanced ultrasound dataBenjamin Theek, Tatjana Opacic, Zuzanna Magnuska, et al.
Pageof 35